Targeting the IL-2/regulatory T cell axis for autoimmune disease prevention in realistic animal models

靶向 IL-2/调节性 T 细胞轴在真实动物模型中预防自身免疫性疾病

基本信息

项目摘要

Project Summary Pathological autoimmunity occurs when the immune system attacks healthy tissue, causing immunopathology and tissue dysfunction. There are over 80 recognized autoimmune diseases that afflict 25-50 million Americans, and this represents a significant financial and public health burden. The experimental mouse has been a standard model of autoimmune research for several decades. However, although research in mice has led to most of the fundamental insights into the development and function of the mammalian immune system, restoration of self-tolerance has been relatively easy to achieve in mouse models of autoimmune disease and many of these findings have been difficult to translate into effective therapies for human autoimmunity. This is likely due to 1) Fundamental differences in immune pathways responsible for tolerance induction in mouse vs. human, and 2) Differences in the immune environment between carefully housed and monitored experimental mice and the more heterogeneous and daunting immune challenges faced by humans, who are exposed to continual acute and chronic infection along with an array of environmental exposures that can damage tissues and provoke immune reactions. This highlights the need to study immune tolerance in animal models that more closely resemble human immune systems, and account for each of these important factors. The goal of this proposal is to use novel and realistic mouse models that more closely mirror human immune function to study tolerance induction via manipulation of the IL-2/TR cells axis, and identify critical parameters that influence the outcome of therapies aimed at preventing or ameliorating autoimmune disease.
项目摘要 当免疫系统攻击健康组织时,就会发生病理性自身免疫, 和组织功能障碍。有超过80种公认的自身免疫性疾病, 美国人,这是一个重大的财政和公共卫生负担。实验小鼠具有 几十年来一直是自身免疫研究的标准模型。然而,尽管在老鼠身上的研究 导致了对哺乳动物免疫系统的发展和功能的大部分基本见解, 在自身免疫性疾病的小鼠模型中, 这些发现中的许多难以转化为人自身免疫的有效疗法。这是 可能是由于1)负责小鼠与小鼠中耐受诱导的免疫途径的根本差异。 2)精心饲养和监测的实验动物之间免疫环境的差异 小鼠和人类面临的更异质和艰巨的免疫挑战,谁暴露在 持续的急性和慢性感染沿着一系列可能损害组织的环境暴露 引发免疫反应这突出了在动物模型中研究免疫耐受的需要, 更接近于人类的免疫系统,并解释了这些重要因素中的每一个。的目标 这项提议是使用新的和现实的小鼠模型,更接近地反映人类的免疫功能, 研究通过操纵IL-2/TR细胞轴诱导耐受,并确定关键参数, 影响旨在预防或改善自身免疫性疾病的治疗结果。

项目成果

期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
An IL-2 mutein engineered to promote expansion of regulatory T cells arrests ongoing autoimmunity in mice.
  • DOI:
    10.1126/sciimmunol.aba5264
  • 发表时间:
    2020-08-14
  • 期刊:
  • 影响因子:
    24.8
  • 作者:
    Khoryati L;Pham MN;Sherve M;Kumari S;Cook K;Pearson J;Bogdani M;Campbell DJ;Gavin MA
  • 通讯作者:
    Gavin MA
In Vivo Expansion of Antigen-Specific Regulatory T Cells through Staggered Fc.IL-2 Mutein Dosing and Antigen-Specific Immunotherapy.
通过交错 Fc.IL-2 突变蛋白剂量和抗原特异性免疫疗法体内扩增抗原特异性调节 T 细胞。
  • DOI:
    10.4049/immunohorizons.2100051
  • 发表时间:
    2021
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Pham,MinhN;Khoryati,Liliane;Jamison,BraxtonL;Hayes,Erika;Sullivan,JennaM;Campbell,DanielJ;Gavin,MarcA
  • 通讯作者:
    Gavin,MarcA
Regulatory T Cells Maintain Selective Access to IL-2 and Immune Homeostasis despite Substantially Reduced CD25 Function.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Daniel J Campbell其他文献

133 CARDIAC PERFORMANCE, EXERCISE CAPACITY AND PULMONARY FUNCTION AFTER FONTAN SURGERY
Fontan 手术后心脏功能、运动能力和肺功能
  • DOI:
    10.1203/00006450-198504000-00163
  • 发表时间:
    1985-04-01
  • 期刊:
  • 影响因子:
    3.100
  • 作者:
    David G Ruschhaupt;Daniel J Campbell;Otto G Thilenius;Robert L Replogle;Rene A Arcilla
  • 通讯作者:
    Rene A Arcilla
Evaluating YouTube Videos on Facelift Surgery for Facial Rejuvenation as a Resource for Patients
评估有关面部年轻化整容手术的 YouTube 视频作为患者的资源
  • DOI:
    10.1177/00034894231154410
  • 发表时间:
    2023
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Zachary T Elliot;Joseph S Lu;Daniel J Campbell;Kevin B Xiao;Vanessa Christopher;Howard Krein;R. Heffelfinger
  • 通讯作者:
    R. Heffelfinger
Differences in Functional and Survival Outcomes Between Patients Receiving Primary Surgery vs Chemoradiation Therapy for Treatment of T1-T2 Oropharyngeal Squamous Cell Carcinoma.
接受初次手术与放化疗治疗 T1-T2 口咽鳞状细胞癌的患者功能和生存结果的差异。
  • DOI:
    10.1001/jamaoto.2023.1944
  • 发表时间:
    2023
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Dev R Amin;R. Philips;Dylan G Bertoni;Eric V Mastrolonardo;Daniel J Campbell;A. Agarwal;Sruti Tekumalla;Zachary D Urdang;A. Luginbuhl;D. Cognetti;Joseph M. Curry
  • 通讯作者:
    Joseph M. Curry
Evaluating ChatGPT responses on thyroid nodules for patient education.
评估 ChatGPT 对甲状腺结节的反应以进行患者教育。
Evaluating ChatGPT Responses on Atrial Fibrillation for Patient Education
评估 ChatGPT 对心房颤动的反应以进行患者教育
  • DOI:
    10.7759/cureus.61680
  • 发表时间:
    2024
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Thomas J Lee;Daniel J Campbell;Abhinav K Rao;Afif Hossain;Omar Elkattawy;Navid Radfar;Paul Lee;Julius M Gardin
  • 通讯作者:
    Julius M Gardin

Daniel J Campbell的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Daniel J Campbell', 18)}}的其他基金

Mechanisms of Il-2-mediated immune tolerance
IL-2介导的免疫耐受机制
  • 批准号:
    10608299
  • 财政年份:
    2023
  • 资助金额:
    $ 67.93万
  • 项目类别:
Reprogramming of tissue structural cells by cutaneous CD4+ T cells
皮肤 CD4 T 细胞对组织结构细胞的重编程
  • 批准号:
    10608777
  • 财政年份:
    2023
  • 资助金额:
    $ 67.93万
  • 项目类别:
Control of CD8+ T cell migration and activation by Flightless-1
Flightless-1 控制 CD8 T 细胞迁移和激活
  • 批准号:
    10155177
  • 财政年份:
    2021
  • 资助金额:
    $ 67.93万
  • 项目类别:
Mechanisms of autoimmune disease risk in IL2/IL2RA-dependent immune tolerance
IL2/IL2RA依赖性免疫耐受中自身免疫性疾病风险的机制
  • 批准号:
    10358624
  • 财政年份:
    2021
  • 资助金额:
    $ 67.93万
  • 项目类别:
Control of CD8+ T cell migration and activation by Flightless-1
Flightless-1 控制 CD8 T 细胞迁移和激活
  • 批准号:
    10366045
  • 财政年份:
    2021
  • 资助金额:
    $ 67.93万
  • 项目类别:
Mechanisms of autoimmune disease risk in IL2/IL2RA-dependent immune tolerance
IL2/IL2RA依赖性免疫耐受中自身免疫性疾病风险的机制
  • 批准号:
    10553203
  • 财政年份:
    2021
  • 资助金额:
    $ 67.93万
  • 项目类别:
Regulation of cutaneous immunity and tissue-repair by a specialized population of CD4+ T cells
特殊 CD4 T 细胞群对皮肤免疫和组织修复的调节
  • 批准号:
    9384627
  • 财政年份:
    2017
  • 资助金额:
    $ 67.93万
  • 项目类别:
Regulation of cutaneous immunity and tissue-repair by a specialized population of CD4+ T cells
特殊 CD4 T 细胞群对皮肤免疫和组织修复的调节
  • 批准号:
    9926223
  • 财政年份:
    2017
  • 资助金额:
    $ 67.93万
  • 项目类别:
Targeting the IL-2/regulatory T cell axis for autoimmune disease prevention in realistic animal models
靶向 IL-2/调节性 T 细胞轴在真实动物模型中预防自身免疫性疾病
  • 批准号:
    10062808
  • 财政年份:
    2017
  • 资助金额:
    $ 67.93万
  • 项目类别:
Control of CD8+ T cell activation and differentiation by the signaling adaptor BCAP
信号适配器 BCAP 控制 CD8 T 细胞活化和分化
  • 批准号:
    9177685
  • 财政年份:
    2016
  • 资助金额:
    $ 67.93万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 67.93万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 67.93万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 67.93万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 67.93万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 67.93万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 67.93万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 67.93万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 67.93万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 67.93万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 67.93万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了